Clinical Trials – Real World Evidence
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Real-World Evidence (RWE) trials are crucial for further understanding newly approved medicinal products in the real-world setting. These trials provide clinical evidence of the long-term safety and efficacy of these drugs from real-world data where patients are treated using these drugs. RWE trials mainly involve observational data outside the traditional involvement of randomized controlled trials. Using real-world data is an integral part of RWE trials as it allows researchers to monitor and assess patient outcomes and treatment methods. It also allows for the effects of a medicinal product to be investigated over a long period of time.
Scope
The clinical trials data used for these analyses were extracted from GlobalData’s Clinical Trials Database. The report focuses on RWE trials where the data was sourced from the clinical trial database and all clinical trials were initiated between 2001 to 2021. The data have been analyzed by year, phase, status, therapy area, indication, geography, sponsor type (top industry sponsors versus non-industry sponsors), and reasons for discontinuation. In this report, a small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, Phase II, Phase III, and Phase IV trials, respectively.
Reasons to Buy
Understand how RWE trials are beneficial
The trends of RWE clinical trials
Global uptake and usage of RWE trials
Table of Contents
Table
Figures
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.